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RESEARCH ARTICLE Open Access
The early immune response to infection of
chickens with Infectious Bronchitis Virus
(IBV) in susceptible and resistant birds
Jacqueline Smith1*†, Jean-Remy Sadeyen2†, David Cavanagh2, Pete Kaiser1 and David W. Burt1
Abstract
Background: Infectious Bronchitis is a highly contagious respiratory disease which causes tracheal lesions and also
affects the reproductive tract and is responsible for large economic losses to the poultry industry every year. This is
due to both mortality (either directly provoked by IBV itself or due to subsequent bacterial infection) and lost egg
production. The virus is difficult to control by vaccination, so new methods to curb the impact of the disease need
to be sought. Here, we seek to identify genes conferring resistance to this coronavirus, which could help in
selective breeding programs to rear chickens which do not succumb to the effects of this disease.
Methods: Whole genome gene expression microarrays were used to analyse the gene expression differences,
which occur upon infection of birds with Infectious Bronchitis Virus (IBV). Tracheal tissue was examined from control
and infected birds at 2, 3 and 4 days post-infection in birds known to be either susceptible or resistant to the virus.
The host innate immune response was evaluated over these 3 days and differences between the susceptible and
resistant lines examined.
Results: Genes and biological pathways involved in the early host response to IBV infection were determined
andgene expression differences between susceptible and resistant birds were identified. Potential candidate genes
for resistance to IBV are highlighted.
Conclusions: The early host response to IBV is analysed and potential candidate genes for disease resistance are
identified. These putative resistance genes can be used as targets for future genetic and functional studies to prove
a causative link with resistance to IBV.
Keywords: Chicken, Infectious bronchitis virus, Microarray, Disease resistance, Candidate gene
Background
Infectious bronchitis (IB) is a highly contagious respiratory
disease of chickens first described in the USA in the
1930’s [1–3]. Clinical signs include: coughing, sneezing,
rales and nasal discharge. The disease can also affect the
reproductive organs, which leads to a decrease in egg
quality and production, thus making it a major cause of
economic losses within the poultry industry [4]. The
causative virus, Infectious Bronchitis Virus (IBV) is a cor-
onavirus, which is an enveloped virus with a single
positive-stranded RNA genome, which replicates in the
host cell cytoplasm [5]. Proteins encoded by IBV include
the viral RNA polymerase, structural spike proteins, mem-
brane and nucleocapsid and various other regulatory pro-
teins. The spike glycoprotein mediates cell attachment
and plays a significant role in host cell specificity [6].
The existence of many different IBV serotypes, which
are not cross-protective means that control of IB, is very
difficult. Mortality is usually fairly low (~5 %), however
some strains of the virus can also cause nephritis meaning
that, depending on strain, mortality can be greater than
50 % [7, 8] or even up to 80 % with some Australian iso-
lates [9]. IBV infection leaves birds more susceptible to
colibacillosis [10] and subsequent bacterial infections can
also lead to a high level of mortality [11]. Currently, atten-
uated live vaccines are used in broilers and pullets, and
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killed vaccines are used in layers and breeders [12]. How-
ever, virus control is very difficult, as there are only a few
vaccine types and many different strains of IBV. The virus
also continues to mutate rapidly, generating more virulent
strains of the disease [13–15]. Coronaviruses have now
also been detected in other avian species such as turkey,
duck, goose, pheasant, guinea fowl, teal, pigeon, peafowl
and partridge [4].
The extent to which the virus affects the host is highly
dependent on the chicken breed [4] and the MHC B
locus is known to play a role in susceptibility to the virus
[16]. In this study we attempt to identify non-MHC
genes, which may be involved in resistance to IBV. No
genetic analyses have thus far been undertaken in order
to try and do this and no quantitative trait loci or genes
associated with resistance have been determined, so far.
Based on differential gene expression in susceptible and
resistant lines of chickens, we identify potential candi-
date genes for disease resistance towards IBV (virulent
M41 strain). Building on the previous work by Dar et al.
[17] and Wang et al. [18] we used Affymetrix whole-
genome chicken microarrays to examine the tracheal
gene expression profiles of a line of birds known to be
susceptible to IBV infection (line 15I) and a line known
to show resistance (line N). We determined the early
host response to infection and propose possible candi-
date genes for involvement in disease resistance towards
IBV. Understanding how coronaviruses infect the host
and identifying genes involved in resistance is important
not only for the poultry industry but also has important
implications for human health, as diseases such as SARS
are also caused by coronaviruses [19, 20].
Methods
Ethics statement
All animal work was conducted according to UK Home
Office guidelines and approved by the Roslin Institute
Animal Welfare and Ethical Review Body.
Experimental animals
The lines used in these experiments are an IBV suscep-
tible line – line 15I (inbred White Leghorn strain) [21]
and an IBV resistant line – line N (non-inbred Cornell
strain). Line 15I was developed at East Lansing in the
USA in the 1940s [22] and Line N at Cornell, USA in
the 1960s [23]. The lines have since been maintained at
the Institute for Animal Health in Compton, UK. Two-
week-old chicks from each line (15I and N) were sepa-
rated into two experimental rooms, with ad libitum ac-
cess to food and water. In one room, 54 birds (27 from
each line) were infected with 4 log10 CID50 (10
4 CID50)
of virulent IBV-M41 strain in a total of 100 μl of 0.2 %
BSA in PBS equally by intra nasal and ocular routes. In
the other room, 54 control birds (27 from each line)
received 100ul PBS via the same route. Trachea samples
(upper half ) were collected at 2, 3 and 4 days post-
infection (9 individual birds from each line at each time
point). The trachea of infected and control birds from
each line were analysed for viral load using Taqman
real-time quantitative RT-PCR assays.
RNA preparation
Tissue samples (~30 mg) were stabilized in RNAlater
(Ambion, Life Technologies, Paisley, UK) and disrupted
using a bead mill (Retsch MM 300, Retsch, Haan,
Germany) at 20 Hz for 4 min. Total RNA was prepared
using an RNeasy kit (Qiagen, Crawley, UK) extraction
method as per the manufacturer’s protocol. Samples
were resuspended in a final volume of 50 μl of RNAse-
free water. Concentrations of the samples were calculated
by measuring OD260 and OD280 on a spectrophotometer
(Nanodrop, Thermo Scientific, Paisley, UK). Quality of the
RNA was checked on a bioanalyser (Agilent Technologies,
South Queensferry, UK). An RNA integrity number
(RIN) > 8 proved the integrity of the RNA.
Whole genome gene expression microarray hybridization
Biotinylated fragmented cRNA was hybridized to the
Affymetrix Chicken Genome Array. This array contains
comprehensive coverage of 32,773 transcripts corre-
sponding to over 28,000 chicken genes. The Chicken
Genome Array also contains 689 probe sets for detecting
684 transcripts from 17 avian viruses. For each experi-
mental group (control and infected birds in each of the
two lines at each of 2, 3 and 4 dpi), three biological repli-
cates (3 RNA pools from 3 birds) were hybridized. Thus,
36 arrays were used in total. Hybridization was performed
at 45 °C for 16 hours in a hybridization oven with constant
rotation (60 rpm). The microarrays were then automatic-
ally washed and stained with streptavidin-phycoerythrin
conjugate (SAPE; Invitrogen, Paisley, UK) in a Genechip
Fluidics Station (Affymetrix, Santa Clara, CA). Fluores-
cence intensities were scanned with a GeneArray Scanner
3000 (Affymetrix, Santa Clara, CA). The scanned images
were inspected and analyzed using established quality
control measures. Array data have been submitted to
Array Express (http://www.ebi.ac.uk/arrayexpress/) under
the Accession Number E-TABM-1128.
Statistical analysis
Gene expression data generated from the GeneChip Op-
erating Software (GCOS) was normalised using the
PLIER (probe logarithmic intensity error) method [24]
within the Affymetrix Expression Console software pack-
age. This normalised data was then analysed using the
limma and FARMS [25] packages within R in Biocon-
ductor [26]. Probes with a False Discovery Rate (FDR)
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Table 1 Primers used in QRT-PCR analysis
Gene Forward primer Reverse primer Probe primer Opt. primer conc. Probe (μM) GenBank
28S GGCGAAGCCAGAGGAAACT GAC GACCGATTTGCACGTC AGGACCGCTACGGACCTCCACCA 0.6 5 FM165415
C1S GCGCAAAGGCTGGAAAATAC TCAAGAACAGAATTGGGAGTGACA TACTATGCTGAACCCATAACCTGTCTCCCG 0.6 5 NM_001030777
CCL13 CAGAGCCTGGCCCAGAGA TGTCCATTTTGATTCTTCTGGTATG CTGTGCCTGACAAGTGCTGCTTCAACTT 0.2 5 XM_415779
CCLi7 (ah221) CACAACCTGCTGCTTCTCCTATG TGTAGGCGGAGGCAATGAG TCAACGTCCCGTCCCACGCA 0.2 5 AY037860
CD38 GCTTGATGGGCTTTCATGGT CACATTCACTCCATTTTGGACAA ACCCCTCAGCTCCAGGAATCAACTATGAA 0.6 5 XM_420774
CLU TGAGTCAGAATCCCGTAACTTCAG GCAGTCCACAGCCAAGATCTC AGATCCGGCGCAACTCGGCC 0.2 5 NM_204900
COX11 TGGGATCTCCACCTACAACGTA CAGCCACTGTTCTTCAAAACAAA TGCCCTTCGAAGCAGGACAGTACTTCA 0.4 5 XM_001233972
DDT GGCCCCGAGCGGATT CATGACTGTTCTGTTCTTGCCAAT CATTCGCTTTTACCCGCTGGAGCC 0.8 5 NM_001030667
FK-506-BP51 CGGAGGATCAAGAGGAAAGGA CAGAACCCCTCCAGGTGAATT AAGGCTATTCCAACCCCAACGAAGGTG 0.1 5 NM_001005431
HSC20 GGAAATCATGGAAATCAATGAGAAA CACCTCTTTGGTCAGTTCTTCTTG CAGAGCCCGAGAACGACGAGATCC 0.8 5 XR_026662
IFNAR2 TGGTCACTGCATCTCTAAATAAACATT CTGCAATTGTGATGCCATAATAATC CATCCCATCAGCCTGGAAATGCATAACT 0.4 5 NM_204858
IGFBP5 GAAGAGCAGCCAGAGGATGGT GCTTGCACTGCTTCCTCTTGT CACCTCCCCAACTGCGACCGAAA 0.1 5 XM_422069
IRF-7 ACCCGGACCGCCGTAT GCCCAGGCCTTGAAGATCTC CATCCCTTGGAAGCACAACGCCA 0.6 5 NM_205372
MAFK GCGATGATGAACTCGTGTCAA TTCAGACGGATGACCTCCTCTT TCCGTACGGGAGCTGAACCAGCAC 0.4 5 NM_204756
MAP4K4 TGCTATTGAAATGGCTGAAGGA TCCGTGGGATGAGGAAGAGT TCCTCCCCTGTGTGACATGCACCC 0.2 5 NM_001031126
MMD2 TGCCACGCACGCATTCT GGTCATCGGAGAGGACGTAGAG TCCTGCCCAGCATCCTCGGC 0.4 5 XM_414787
MX1 TGGACTTCTGCAACGAATTGTC ATCCAGAAGAGTGCTGAAATGTTTG TTCACCTCCGCAATCCAGCAAGAGA 0.6 5 NM_204609
SRI TACTATCAGGGCGGGTATGGA AGCAAAATAACCATACAGAGGATCCT CAGCTCCAGGAGGCCCATCATTCC 0.1 5 NM_001080865
SUCLG2 AGCTTCCCGGCTGTTCAAT CATGGTCTGCCATCAGCTTTT AACCCCTAGACGATGGCTGAATCTGCA 0.1 5 NM_001006141
TLR3 ATCCATGGTGCAGGAAGTTTAAG GATGGAGTCTCGACTTTGCTCAATA TGCATCATGCTTTACAGC 1.0 5 JF273967.1
TNFAIP1 GTTGTGGGAAGCACTTTGGAA TCAACTCCTTGATCTCCTGTCTGT CCGAGATGACACAATTGCACTTCCAAAA 0.2 5 NM_001030726
TP-D53 TGGCCAAGCTAGAGGATGAAA TCAGGCTCATGCCAAGTTTTT ACTAGCAGCCAAAGAAAAGCACCTGATTGA 0.2 5 NM_204215
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value <0.05 and a fold change ≥1.5 were deemed to be
biologically significant.
Analysis of differentially-expressed genes
In order to determine which biological pathways are in-
volved in the responses to viral infection, we analysed
our differentially-expressed (DE) genes using Pathway
Express [27, 28] which uses KEGG pathways [29] to pic-
torially display up/down regulation of genes. (NB. These
diagrams are based on the human pathways and so are
not completely representative of the chicken pathways).
Genes differentially expressed during the host response
(FDR <0.05) were analysed against a reference background
consisting of all genes expressed in the experiment. Fac-
tors considered by Pathway Express include the magni-
tude of a gene’s expression change and its position and
interactions in any given pathway, thus including an ‘im-
pact factor’ when calculating statistically significant path-
ways. Anything with a p-value <0.25 is deemed significant
when using this software. Use of the Ingenuity Pathway
Analysis (IPA) program [30] revealed which canonical
pathways are being switched on by IBV infection in the
host (with Benjamini-Hochberg multiple testing correc-
tion) and allowed us to analyze the gene interaction net-
works involved in the host response. Genes were clustered
by similar expression pattern and analysed for enriched
GO-terms and transcription factor binding sites (TFBS)
using Expander (v5.2) [31]. Normalised expression data
from control samples were compared with infected sam-
ples to examine the host response to IBV infection. En-
richment analysis of particular GO terms or TFBS within
clusters was done using the TANGO and PRIMA func-
tions, respectively, within the Expander package.
Viral quantification and specific gene expression analysis
by quantitative real-time PCR
Taqman real-time quantitative RT-PCR (qRT-PCR) was
used to quantify viral RNA levels and for confirmation
of the microarray results for the mRNA levels of selected
genes. This was performed on 3 replicate pools of 3
samples (9 birds). Primers (Sigma) and probe (PE Ap-
plied Biosystems, Warrington, UK) (Table 1) were de-
signed using Primer Express (PE Applied Biosystems).
Briefly, the assays were performed using 2 μL of total
RNA and the Taqman FAST Universal PCR Master Mix
and one-step RT-PCR mastermix reagents (PE Applied
Biosystems) in a 10 μL reaction. Amplification and de-
tection of specific products were performed using the
Applied Biosystems 7500 Fast Real-Time PCR System
with the following cycle profile: one cycle at 48 °C for
30 min and 95 °C for 20 sec, followed by 40 cycles at
95 °C for 3 sec and 60 °C for 30 sec. Data are expressed
in terms of the cycle threshold (Ct) value, normalised for
each sample using the Ct value of 28S rRNA product for
the same sample, as well described previously [32–34].
Final results are shown as 40-Ct using the normalised
value, or as fold-change from uninfected controls.
Results and discussion
Assessment of viral load
Taqman real-time quantitative RT-PCR analysis was
used to measure viral load in trachea samples from both
control and infected birds from both lines 15I and N.
Tracheal tissue was chosen for examination in this study
as the target of IBV is the epithelial surface of the re-
spiratory tract. Viral RNA was detected in infected birds,
but no significant difference in viral load was detected
between lines at any of the days 2, 3 or 4 post infection
(Fig. 1). This would indicate that the resistance to the
virus seen in Line N is due to how the birds respond to
the virus once it has entered the body and is not a meas-
ure of how the birds can prevent initial infection by the
virus itself. When resistance to IBV infection was origin-
ally determined in these lines, it was noted that they were
equally susceptible to infection, but a variation in outcome
was seen. In line N, 33 % of birds showed air sac lesions
whereas 73 % of 15I birds presented lesions. Mortality was
0 in line N, but 47 % within line 15I birds. It was hypothe-
sized that the different lines were producing different im-
munological responses upon infection [21].
Host response to IBV infection
Gene expression differences found in the susceptible 15I
line between infected and control birds over days 2, 3 and
4 post infection were analysed, with a view to examining
the innate host response to infection by IBV. Genes seen
to be induced during the host response to infection in-
clude C1S, IRF1, STAT1, MX1, TLR3 and CTSS as previ-
ously recognised by Guo et al. [35]. We also identified
IFIT5, OASL, SCA2, LYG2, ISG12-2, DDX60, IFIH1, IRF7,
0
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Fig. 1 QRT-PCR measurement of viral load in control and infected
birds from lines 15I and N. Mean 40-Ct values are shown with the
standard error mean indicated
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ZC3HAV1, DHX58, CCli7, IFITM1 and IFITM3 as being
up-regulated in response to IBV infection. Few genes
are seen to be down-regulated during the early stage
of the host response, but those which are include
CHAC1 (pro-apoptotic), HBB (implicated in inflammation
regulation) and PDK4 (glucose regulation). For a full list
Fig. 2 Pathway Express analysis of the host response to IBV infection in the trachea of susceptible birds (Line 15I). Many genes involved in
antigen processing and presentation (a) and in the Toll-like receptor pathway (b) can be seen to be up-regulated (shown in red)
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of the genes involved in the tracheal immune response
(133 DE probes), see Additional file 1: Table S1.
To elucidate which biological pathways are being per-
turbed during the host response to IBV infection, we ana-
lysed our data using Pathway Express [36]. The resulting
pathway diagrams are extremely useful in establishing
which gene networks are involved in a particular experi-
mental response. As seen in Fig. 2, genes involved in anti-
gen presentation and the Toll-like receptor (TLR)
pathway are up-regulated. TLRs identify pathogen associ-
ated molecular patterns (PAMPs) and are crucial to the
innate immune system. In this study TLR3 is shown to be
Table 2 Pathway Express analysis of the host response to IBV infection
Rank Pathway name Impact Factor Input genes/Genes in Pathway Corrected gamma p-value
1 Antigen processing and presentation 14.244 6/89 9.93E-06
2 Toll-like receptor signaling pathway 7.927 5/102 0.003221463
3 Notch signaling pathway 7.073 3/47 0.006843371
4 Pancreatic cancer 4.448 3/72 0.06375221
5 Maturity onset diabetes of the young 3.952 1/24 0.095158775
6 Phosphatidylinositol signaling system 3.884 2/76 0.100456001
7 Complement and coagulation cascades 3.841 3/69 0.103946526
8 mTOR signaling pathway 3.652 2/52 0.120669151
9 Acute myeloid leukemia 3.448 2/59 0.141487282
10 Systemic lupus erythematosus 3.332 2/144 0.15474593
11 VEGF signaling pathway 3.126 2/74 0.181102595
a
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Fig. 3 Ingenuity Pathway Analysis (IPA) of genes responding to IBV infection. a Canonical biological pathways which are activated in the host
upon IBV infection (p < 0.05). The line represents the ratio of genes represented within each pathway. b The most highly represented (p < 0.05)
physiological functions of genes differentially expressed during the host response to IBV (in the trachea in susceptible birds (Line 15I)). Specific
functions within groups are highlighted
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Fig. 4 Gene expression cluster analysis of the host response in susceptible birds (Line 15I) using the Expander program (http://acgt.cs.tau.ac.il/
expander/expander.html). a The expression profile of genes up-regulated during the response to virus. b The GO biological process terms which
are significantly enriched during the host response to infection. The frequency of genes of a functional class within the examined set is described
as a percentage. c Binding sites for the transcription factors IRF7 and ISRE are seen to be significantly over-represented in genes up-regulated
during the host response to IBV infection. The frequency ratio (frequency in set divided by frequency in background) is shown
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induced at 3 dpi. TLR3 recognizes double-stranded RNA
intermediates produced during viral replication and has
previously been shown to be induced in the trachea at this
time after IBV infection [37]. Another pathway involved is
the phosphatidylinositol signalling pathway (Table 2).
Phosphatidylinositol kinases are known to play an import-
ant role in the viral life cycle after infection of the host
and PI4KB is known to be exploited by coronaviruses for
viral entry. The product of PI4KB catalysis is phos-
phatidylinositol 4-phosphate (PI4P) and coronavirus entry
into the host is mediated by the PI4P lipid microenviron-
ment [38]. Genes involved in the complement system are
also highlighted as being up-regulated in response to IBV
infection. Complement-mediated lysis of viruses is an im-
portant facet of the host innate immune system and its
role in defence against viral infection [39] – as reflected in
the induction of these genes in this study.
Use of Ingenuity Pathway Analysis (IPA) software also
allowed us to determine which biological systems are ac-
tive during the host response. Up-regulated genes are
seen to be part of the canonical biological pathways
shown in Fig. 3a. Biological processes involving pattern
recognition receptors and interferon signalling feature
heavily. The interferon response is a powerful antiviral
mechanism, which has previously been shown to be in-
volved in the host response after IBV infection. A very
early induction of IFN-γ has been reported in spleno-
cytes [40], and in peripheral blood mononuclear cells
(PBMCs) and lung leukocytes [41]. IFNB expression has
also been reported in trachea between 1 and 2 dpi [42].
We do not see this increase in expression of interferon
genes (due to the absence of data earlier than 2 dpi), but
we do see the downstream effects, with increased ex-
pression of many interferon-induced genes. Specific
physiological processes activated upon IBV infection can
also be seen in Fig. 3b. The stimulation of various different
immune cells is seen along with the indication of repro-
ductive abnormality, which would reflect the problems
seen with egg-laying upon IBV infection.
In order to cluster genes seen to be involved in the
host response to infectious bronchitis into groups with
similar expression profiles and probably sharing similar
functions or gene regulatory pathways, we utilised the
CLICK algorithm within the Expander program [43].
Figure 4a shows the expression profile of genes up-
regulated during the response to virus. The Expander
program was also used to analyse the Gene Ontology
(GO) functional annotations of the genes being differ-
entially expressed. Figure 4b shows the biological
process terms, which are significantly enriched in the
genes responding during the host response to infec-
tion. As would be expected, these include terms like
‘innate immune response’ and ‘antigen processing and
presentation’. ‘NAD + ADP-ribosyltransferase activity’
and ‘phosphoinositide binding’ are also highlighted.
Transcription factor binding sites present in DE genes
which are significantly over-represented were also
predicted. Figure 4c shows that genes up-regulated
during the host response have a high proportion of
IRF7 and ISRE binding sites. IRF7 is a transcriptional
activator, which binds to the interferon-stimulated re-
sponse element (ISRE) in IFN promoters and functions as
a molecular switch for antiviral activity.
Differences between susceptible and resistant lines
Analysis of the gene expression differences between in-
fected and control birds across the two lines has pro-
vided us with information on how these lines differ in
their response to infection. Examination of the gene ex-
pression profiles in the control birds of the two different
lines also allowed us to identify genes, which are inher-
ently different between the susceptible and resistant
birds. It can be seen that there are numerous genes,
which show large expression differences between the
two lines, even before infection. Dramatic differences in
gene expression of certain genes, including DDT, SRI,
BLB1, HSCB, BF1, BF2, SUCLG2, MX1 and SRI, which
are more highly expressed in the resistant N line
Fig. 5 Ingenuity Pathway Analysis (IPA) of genes showing inherent differential expression between susceptible and resistant control birds. This
graph shows the most highly represented (p < 0.05) molecular functions of DE genes
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Fig. 6 Ingenuity Pathway Analysis (IPA) of genes showing differential expression between susceptible and resistant lines during the host response
to IBV infection. a The most highly represented (p < 0.05) molecular functions of DE genes. b This biological network shows genes associated
with connective tissue disorders. Genes shown in red are more highly expressed in the resistant line and those in green have higher expression
in the susceptible line
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compared to the susceptible 15I line are noted (Add-
itional file 2: Table S2 shows all 1930 DE probes) So, it
can be seen that these are genes which have inherently
different expression levels between susceptible and re-
sistant birds, even before infection occurs. We therefore
postulate that some of these genes may play an im-
portant role in disease resistance. The potential inter-
actome of IBV has recently been investigated by
stable isotope labelling with amino acids in cell cul-
ture (SILAC) coupled to a green fluorescent protein-
nanotrap pull-down methodology [44]. Host proteins,
which bind to the IBV N protein were identified,
some of the genes for which, we see as being inher-
ently expressed at higher levels in susceptible birds in
this study. These genes include MYH9, CAPRIN1,
DHX57, HNRNPH3, RPL27A, FMR1, C22orf28, HNRPDL,
SFRS3, RPL31, NPM1 and RPSA. This may therefore be
one of the reasons why Line 15I is more susceptible to
IBV infection – there are more host proteins to which the
virus binds, compared with the resistant Line N.
Upon infection, differences in response are also seen be-
tween the two lines. Interestingly, apart from CD38 and
CD4 at 3 dpi and FKBP5 at 4 dpi, all other differential
gene expression between the lines is seen at 2 dpi in this
study (Additional file 3: Table S3). CD38 is a glycoprotein
found on the surface of many immune cells including
CD4+, CD8+, B lymphocytes and natural killer cells and is
a marker of cell activation. It functions in cell adhesion,
signal transduction and calcium signalling. CD4 is found
on the surface of immune cells such as T helper cells,
monocytes, macrophages and dendritic cells. It is a mem-
brane glycoprotein which interacts with MHCII antigens.
The protein functions to initiate or augment the early
phase of T-cell activation. The protein encoded by FKBP5
is a member of the immunophilin protein family, which
play a role in immuno-regulation and basic cellular pro-
cesses involving protein folding and trafficking. Early de-
fence by the host is a key mechanism for combatting viral
infection, and induction of IFNB and other innate genes
in response to IBV infection has been shown to peak
around 18–36 hr post infection [42].
In this study, genes more highly expressed (or less
down-regulated) in the resistant N line at 2 dpi include a
number of collagen genes (COL3A1, COL1A2, COL9A1,
COL9A2, COL6A1 and COL4A1) and other genes such as
ACAN, FSTL1, COMP, EIF3A, STAT3 and IGFBP5. Genes
seen to be more highly expressed (or less down-regulated)
in the susceptible 15I line include RBM39, MAFB, NNK2,
CCN1, MGAT5 and THRAP3. One consequence of IBV
infection is the production of poor quality, misshapen eggs
by infected birds [45]. Some of the genes previously
identified as being important for the creation of a
Table 3 Genes analyzed by qRT-PCR
Gene Description Fold change GenBank Ensembl
MX1 Interferon-induced GTP-binding protein Mx 6–20 NM_204609 ENSGALG00000016142
C1S complement component 1, s subcomponent 2–4 NM_001030777 ENSGALG00000014603
IRF7 Interferon regulatory factor 7 (IRF-7) 4–5 NM_205372 ENSGALG00000014297
TLR3 Toll-like receptor 3 4 NM_001011691 ENSGALG00000013468
CCLi7 Chemokine ah221 2–12 AY037860 ENSGALG00000002343
CD38 ADP-ribosyl cyclase 1 4–9 XM_420774 ENSGALG00000014508
FKBP5 FK-506 binding protein 51 5–6 NM_001005431 ENSGALG00000000947
IGFBP5 Insulin-like growth factor binding protein 5 1 XM_422069 ENSGALG00000011468
DDT D-dopachrome tautomerase 2–3 NM_001030667 ENSGALG00000006350
SRI sorcin 2 NM_001080865 ENSGALG00000008985
CLU clusterin 2 NM_204900 ENSGALG00000016587
COX11 Cytochrome c oxidase assembly protein COX11, mitochondrial precursor 2 XM_001233972 ENSGALG00000003017
MMD2 Monocyte to macrophage differentiation factor 2 2 XM_414787 ENSGALG00000004530
IFNAR2 interferon alpha/beta receptor 2 2–3 NM_204858 ENSGALG00000015938
TNFAIP1 tumor necrosis factor, alpha-induced protein 1 (endothelial) 2 NM_001030726 ENSGALG00000005715
MAP4K4 mitogen-activated protein kinase kinase kinase kinase 4 2 NM_001031126 ENSGALG00000008970
MAFK Transcription factor MafK. 2 NM_204756 ENSGALG00000004189
CCL13 similar to Small inducible cytokine A13 precursor (CCL13) 3 XM_415779 ENSGALG00000024470
TPD52L1 Tumor protein D53 homolog 13–23 NM_204215 ENSGALG00000014843
HSCB Co-chaperone protein HscB, mitochondrial precursor (Hsc20) 2 XR_026662 ENSGALG00000005706
SUCLG2 succinate-CoA ligase, GDP-forming, beta subunit 2 NM_001006141 ENSGALG00000007652
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healthy eggshell are seen to be more highly expressed
by the resistant N line birds after infection in this study.
These genes include COL1A2, CRELD2, HSP90B1,
P4HB and ERP29 [46]. For a full list of genes differen-
tially expressed between the two lines in trachea (409
DE probes) see Additional file 3: Table S3.
IPA analysis of genes showing different inherent ex-
pression between lines 15I and N shows that the mo-
lecular functions of these genes is primarily concerned
with their involvement in cell death and cell adhesion
(Fig. 5), two processes previously shown to be significant
in infected kidneys [47]. When the differential host re-
sponses to infection are examined, it is seen that genes
involved in proliferation of T-lymphocytes and genes
concerned with cell attachment and cytoplasmic
organization are more highly expressed in the resistant
line N. Other processes significantly involved are apop-
tosis and necrosis (Fig. 6a), which have been previously
documented in IBV-infected Vero cells by Liu et al. [48].
One of the most perturbed biological networks noted in
this analysis is that involving genes related to connective
tissue disorders and involve many collagen genes. These
genes are more highly expressed in susceptible line 15I
birds compared to resistant line N birds (Fig. 6b) sug-
gesting that IBV infection might cause more disorder of
eggshell formation in this line [49]. The production of
poor quality eggs by IBV infected birds may, in part be a
reflection of the expression of these kinds of gene net-
works compared to that seen in resistant birds.
Confirmation of differential gene expression by
quantitative real-time PCR
Twenty-one genes were selected for qRT-PCR validation
(Table 3). These genes were chosen based on their in-
volvement in the host response and whether they were
differentially expressed between the susceptible and re-
sistant lines (either inherently or during the course of in-
fection). Of the 21 genes tested, 19 showed comparable
Table 4 Potential candidate genes for involvement in resistance to IBV
Gene Description Fold change GenBank Ensembl
MX1 Interferon-induced GTP-binding protein Mx. 4–24a NM_204609 ENSGALG00000016142
C1S Complement component 1, s subcomponent 2a NM_001030777 ENSGALG00000014603
IRF7 Interferon regulatory factor 7 (IRF-7). 6a NM_205372 ENSGALG00000014297
TLR3 Toll-like receptor 3 4a NM_001011691 ENSGALG00000013468
C1R Complement component 1, r subcomponent 2a XM_416518 ENSGALG00000014659
CCLi7 Chemokine ah221 8a AY037860 ENSGALG00000002343
ISG12-2 Interferon stimulated gene 12-2 16–18a NM_001001296 ENSGALG00000013575
IFITM3 Interferon induced transmembrane protein 3 4–5a KC876032 ENSGALG00000004243
CD38 ADP-ribosyl cyclase 1 4b XM_420774 ENSGALG00000014508
CD4 CD4 protein 4b NM_204649 ENSGALG00000014477
FKBP5 FK-506 binding protein 51 2b NM_001005431 ENSGALG00000000947
STAT3 Signal transducer and activator of transcription 3 (acute-phase response factor) 3b NM_001030931 ENSGALG00000003267
OASL 2'-5'-oligoadenylate synthetase-like 4c NM_205041 ENSGALG00000013723
DDT D-dopachrome tautomerase 62–72c NM_001030667 ENSGALG00000006350
SRI Sorcin 65–89c NM_001080865 ENSGALG00000008985
BLB1 MHC Class II beta 1 and 2 domains 10–22c NM_001044694 ENSGALG00000000141
IFNAR2 Interferon alpha/beta receptor 2 2–3c NM_204858 ENSGALG00000015938
TPD52L1 Tumor protein D53 homolog 12–14c NM_204215 ENSGALG00000014843
BCL2L1 BCL2-like - apoptosis regulator 1.7c NM_001025304 ENSGALG00000006211
FAIM2 Fas apoptotic inhibitory molecule 2 1.7c XM_004950568 ENSGALG00000027555
CIAPIN1 Cytokine Induced Apoptosis Inhibitor 11 1.7c NM_001005834 ENSGALG00000005706
HSCB Co-chaperone protein HscB, mitochondrial precursor (Hsc20). 8–10c XR_026662 ENSGALG00000005706
BF1 MHC class I antigen B-F minor heavy chain 13–27c NM_001097530 ENSGALG00000000178
BF2 Major class I glycoprotein precursor 7–8c NM_001031338 ENSGALG00000000178
SUCLG2 succinate-CoA ligase, GDP-forming, beta subunit 16–32c NM_001006141 ENSGALG00000007652
aUpregulated in response to infection in the susceptible line
bHigher expression in response to infection in the resistant than in the susceptible line
cInherently higher expression in the resistant line
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differential expression to that determined by the arrays.
However, the results for IFNAR2 and IGFBP5 were not
confirmed (Additional file 4: Figure S1).
Potential candidate genes for IBV resistance
Besides knowing that the MHC B locus has a bearing on
disease resistance, the lack of any genetic information or
identified QTL meant that we had to rely upon the gene
expression differences we saw between susceptible and
resistant lines to give us clues as to genes potentially in-
volved in resistance to IBV infection. Identifying genes
which were expressed at different levels in the two lines
of birds highlighted B-locus genes (BLB1, BF1, BF2, B-G)
as well as bringing to our attention various other
non-MHC genes which, due to their known biology,
could be candidates for being involved in resistance
to IBV infection (Table 4).
MX1, C1S, IRF7,TLR3, C1R, CCLi7, ISG12-2 and IFITM3
are all strongly induced during the host response to IBV in-
fection. They are all innate immune genes which could po-
tentially have a role in determining susceptibility to the
virus. MX1 and IFITM3 are already established as anti-viral
molecules [50–52]. CD38, CD4, FKBP5 and STAT3 all show
a higher level of expression during the host response in the
resistant birds compared to that of the susceptible birds, in-
dicating their involvement in the host defence mechanism.
CD38 and CD4, with their role as receptors on immune
cells, as described above, are obvious candidates, along with
FKBP5 as an immune-regulator. STAT3 is activated by vari-
ous cytokines and growth factors and functions in cellular
processes such as cell growth and apoptosis.
Even before infection, many genes are seen to be highly
differentially expressed between lines 15I and N. OASL is
an interferon-induced molecule known to have anti-viral
activity against certain viruses such as hepatitis C virus.
DDT is highly homologous to the macrophage migration
inhibition factor, MIF. We have also shown it to be highly
differentially expressed in other chicken lines, which are
susceptible or resistant to Marek’s Disease virus [53].
IFNAR2 is an obvious candidate prediction, as the inter-
feron response is central to the host’s defence against IBV
infection. TPD52L1, BCL2L1, FAIM2 and CIAPIN1 are all
known to be involved in regulation of apoptosis, a process
seen to be important during IBV infection. HSCB, SRI, and
SUCLG2, although not having an obvious potential bio-
logical role in disease resistance, are highly differentially
expressed between susceptible and resistant lines and
should thus be considered as potential candidates.
Conclusions
Resistance to IBV infection is brought about by the im-
mune response after the virus has entered the host and
is not due to prevention of initial viral infection. There
is a small initial innate response at 2 dpi, with much
more gene expression seen at 3 and 4 dpi. Analysis of
genes being activated or inhibited upon infection shows
that the biological pathways primarily affected during
IBV infection include MAPK signalling, those involved
in the interferon response and those involving pattern
recognition receptors.
Susceptible and resistant lines show a differential host
response mostly at 2 dpi. There are also genes which are
inherently different between the two lines studied, includ-
ing many genes, which control the apoptotic potential of
the host. These differences seen in gene expression levels,
allow us to postulate on many candidate genes for disease
resistance. Some potential candidates for involvement in
disease resistance include genes already known to confer
resistance to other viral infections (MHC-B locus genes,
MX1, OASL and IFITM3), genes involved in apoptotic
processes (TPD52L1, BCL2L1, FAIM2 and CIAPIN1) and
others which could be potential candidates due to their
known biology (e.g. DDT and CD4).
Availability of supporting data
Array data have been submitted to Array Express
(http://www.ebi.ac.uk/arrayexpress/) under the accession
number E-TABM-1128.
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Additional file 1: Table S1. Gene expression seen during the host
response to IBV infection in the trachea of susceptible birds. (XLSX 24 kb)
Additional file 2: Table S2. Gene expression differences found to be
inherent between susceptible and resistant lines in the trachea. (XLS 386 kb)
Additional file 3: Table S3. Genes found to be differentially expressed
between susceptible and resistant lines in response to IBV infection in
the trachea. (XLS 107 kb)
Additional file 4: Figure S1. qRT-PCR analysis of 21 genes differentially
expressed during IBV infection. (A). MX1 (B). C1S (C). IRF7 (D). TLR3 (E).
CCLi7 (F). DDT (G). SRI (H). CLU (I). COX11 (J). IFNAR2 (K). TNFAIP1 (L).
TP-D53 (M). MAP4K4 (N). MAFK (O). CCL13 (P). HSC20 (Q). SUCLG2 (R).
MMD2 (S). CD38 (T). FK506-BP51 (U). IGFBP5. Graphs A-E show expression
changes during the host response in the susceptible line. Graphs F-R
show inherent differences in gene expression between susceptible and
resistant control birds, while graphs S-U indicate differential gene expression
in susceptible and resistant lines during the host response. (PDF 97 kb)
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